喘儿童运动的障碍和促进因素:定性元合成的协议
Xin Yi1, Kejimu Sunzi2, Xia Wu2
1School of Basic Medical Sciences & School of Nursing, Chengdu University, Chengdu, China.
BMJ open
|January 13, 2026
概括
这项研究探讨了喘儿童运动的障碍和促进因素. 了解这些因素可以改善运动干预措施,提高生活质量.
科学领域:
- 儿科肺病学 儿科肺病学
- 运动科学 运动科学
- 定性研究方法论 定性研究方法论
背景情况:
- 儿童喘患病率正在上升,这使得运动对健康和生活质量至关重要.
- 患有喘的儿童面临着诸如身体限制,恐惧恶化以及父母对运动支持不足等挑战.
- 识别促进或阻碍运动的因素对于有效的喘管理至关重要.
研究的目的:
- 进行定性元合成,探索喘儿童参与运动的障碍和促进因素.
- 为儿童喘提供有针对性的运动干预措施的发展提供信息.
- 通过优化管理,改善喘儿童的健康状况和生活质量.
主要方法:
- 坚持乔安娜·布里格斯研究所 (JBI) 的定性元合成框架.
- 在PubMed,Embase,CINAHL,Web of Science和Cochrane图书馆进行系统的文献搜索,直到2025年12月.
- 来自14岁以下患喘儿童运动的定性或混合方法研究数据的专题综合.
主要成果:
- 运动障碍包括与症状相关的局限性,恶化恐惧和缺乏支持.
- 促进者可能涉及量身定制的计划,支持性环境和清晰的沟通.
- 综合发现将确定影响运动参与的关键主题.
结论:
- 了解运动障碍和促进因素对于有效的儿科喘管理至关重要.
- 基于这些发现的有针对性的干预措施可以提高运动参与和结果.
- 这项研究为通过体育活动改善喘儿童福祉提供了基础.
相关概念视频
Asthma-I: Introduction
3.4K
Asthma is a chronic respiratory ailment that requires careful management due to its varying symptoms and influencing factors. It is characterized by airway inflammation, bronchial hyperresponsiveness, and reversible airflow obstruction, leading to symptoms like wheezing, shortness of breath, chest tightness, and coughing. The symptom frequency and intensity may vary considerably over time. It is also linked to immune system responses to allergens and irritants, highlighting the complex...
3.4K
Asthma-II: Pathophysiology and Classification
4.1K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
4.1K
Asthma: Pathogenesis and Management
1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Asthma-IV: Diagnostic and Management
3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Asthma-III: Symptoms and Complications
3.3K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
3.3K
Asthma-IV: Nursing Management
3.7K
The nursing management of asthma is a comprehensive approach that relies heavily on the expertise and dedication of healthcare professionals. It involves thorough assessment, accurate diagnosis, strategic planning, effective implementation, and diligent evaluation. By meticulously following this step-by-step process, healthcare professionals play a crucial role in providing the best possible care and treatment for patients with asthma, enhancing their overall health and well-being.
First, in...
First, in...
3.7K


